ホーム › アトピー性皮膚炎（湿疹） › オハイオ
オハイオにおけるアトピー性皮膚炎（湿疹）の臨床試験
オハイオ内の拠点で、アトピー性皮膚炎（湿疹）に関する10件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Dermatology Associates of Mid-Ohio- Site Number : 8400026, Marion
- Dermatologists of Southwest Ohio - Mason- Site Number : 8400050, Mason
被験者募集中観察研究
12歳以上 · 全性別 · 2026/09/29更新 · NCT07290803Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Canton
- Enveda Investigative Site, Mayfield Heights
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07298395A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Apex Clinical Research Center, LLC., Mayfield Heights
被験者募集中第2相
18歳〜64歳 · 全性別 · 2026/09/25更新 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Boardman
- Investigational Site, Mason
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07003425A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- ClinOhio Research Services, Columbus
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/08/28更新 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 9, Columbus
- Inmagene Site 5, Mayfield Heights
被験者募集中第2相
18歳〜74歳 · 全性別 · 2026/08/12更新 · NCT07037901A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- DOCS Clinical Research - Canal Winchester /ID# 268271, Canal Winchester
- Wright State Physicians Health Center /ID# 268841, Fairborn
被験者募集中第3相
2歳〜11歳 · 全性別 · 2026/08/06更新 · NCT06461897Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati
被験者募集中第1相
6歳以上 · 全性別 · 2026/07/02更新 · NCT06504160A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Apex Clinical Research Center, Mayfield Heights
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/04更新 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7081, Dayton
被験者募集中観察研究
12歳以上 · 全性別 · 2026/03/13更新 · NCT06988605ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。